Plain-English translation of NCT06867198 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether peanuts and peanut products can help improve the health of people with prediabetes—a condition where blood sugar is higher than normal but not yet diabetic. Researchers will follow adults who eat peanuts, peanut butter, or peanut flour three times per week for six months and measure how this affects their blood sugar control, heart health, brain function, and digestive health. The study will compare these results to people who don't add peanuts to their diet.
Prediabetes affects nearly 100 million Americans and often leads to type 2 diabetes, which increases the risk of heart disease and memory problems. While some research suggests that peanuts may help prevent diabetes and support heart and brain health, no comprehensive study has looked at all these benefits together in people with prediabetes, especially across different racial and ethnic groups.
You likely qualify if…
You likely don't qualify if…
You would eat a measured amount of peanut butter (about 1.5 tablespoons three times per week), dry roasted peanuts (about one-third cup three times per week), or peanut flour (about 2 ounces once per week) for six months. You'll have blood tests, blood pressure checks, imaging scans of your blood vessels and brain, and tests to measure how well your gut is working. You may visit the research center multiple times over the six-month period for these measurements to see how the peanuts are affecting your health.
AI-generated summary from trial data · Sep 3, 2026 · Not medical advice
United States
Sponsor
Georgia State University
Collaborators
United States Department of Agriculture (USDA), The Peanut Institute
Enrollment target
~72 participants
Started
March 2025
Primary completion
September 2027
Age range
20 Years – 59 Years
Last updated on clinicaltrials.gov in September 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Rafaela G Feresin, PhD
Georgia State University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.